|
|
Volumn 354, Issue 9192, 1999, Pages
|
|
HIVNET nevirapine trials.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
NEVIRAPINE;
COST BENEFIT ANALYSIS;
COUNSELING;
DEVELOPING COUNTRY;
DISEASE TRANSMISSION;
ECONOMICS;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
PREGNANCY;
PREGNANCY COMPLICATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
MEDICAL ETHICS;
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIAL;
ANTI-HIV AGENTS;
COST-BENEFIT ANALYSIS;
COUNSELING;
DEVELOPING COUNTRIES;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
NEVIRAPINE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
ETHICS, MEDICAL;
PATIENT SELECTION;
RANDOMIZED CONTROLLED TRIALS;
MLCS;
MLOWN;
|
|
EID: 0033589528
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/s0140-6736(05)70582-1 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
